Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Change in Account Payables of -$458036.1 for Q2 2020, down 197.83% year-on-year from $468174.7 in Q3 2019, and down 791.62% on a QoQ basis from $66226.9 in Q4 2019.
Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020) Analysis & Trends
Alterity Therapeutics (ATHE) has reported Change in Account Payables for 11 consecutive years, with -$458036.1 the latest figure, recorded in Q2 2020.
- Quarterly Change in Account Payables fell 197.83% year-over-year to -$458036.1 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was -$330323.2 (down 95.97% YoY) and the FY2025 annual result came in at -$1.4 million, down 285.48% from the prior year.
- Change in Account Payables fell to -$458036.1 in Q2 2020 per ATHE's latest filing, from $66226.9 in the prior quarter.
- Over the last five years, Change in Account Payables for ATHE reached as high as $468174.7 in Q2 2019 and fell as low as -$604620.8 in Q2 2017.
- A 5-year average of -$190231.9 and a median of -$262171.1 in 2016 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2019 — Change in Account Payables surged 5601.06% — and 2020, when it sank 197.83%.
- Year by year, Change in Account Payables stood at -$262171.1 in 2016, then increased by 9.12% to -$238258.3 in 2017, then tumbled by 70.69% to -$406688.7 in 2018, then jumped by 116.28% to $66226.9 in 2019, then sank by 791.62% to -$458036.1 in 2020.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$458036.1, $66226.9, and $468174.7 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Alterity Therapeutics | 30.00 Bn | 30.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -458,036.14 |
| Jun 30, 2020 | -458,036.14 |
| Dec 31, 2019 | 66,226.92 |
| Dec 31, 2019 | 66,226.92 |
| Jun 30, 2019 | 468,174.70 |
| Jun 30, 2019 | 468,174.70 |
| Dec 31, 2018 | -406,688.66 |
| Dec 31, 2018 | -406,688.66 |
| Jun 30, 2018 | 8,212.07 |
| Jun 30, 2018 | 8,212.07 |
| Dec 31, 2017 | -238,258.31 |
| Dec 31, 2017 | -238,258.31 |
| Jun 30, 2017 | -604,620.84 |
| Jun 30, 2017 | -604,620.84 |
| Dec 31, 2016 | -262,171.08 |
| Dec 31, 2016 | -262,171.08 |
| Jun 30, 2016 | -284,925.64 |
| Jun 30, 2016 | -284,925.64 |
| Dec 31, 2015 | -268,936.71 |
| Dec 31, 2015 | -268,936.71 |